Orforglipron, like all GLP-1 therapies, works best when conceptualized as a long-term or indefinite treatment rather than a temporary intervention, similar to how blood pressure medications manage hypertension without "curing" it
Semaglutide and tirzepatide slow the rate at which your stomach empties, so nausea, vomiting, and digestive distress can occur
However, the majority of research has been conducted in animals, and more comprehensive human studies are needed to establish its long-term safety
Because liraglutide is shorter-acting and taken daily, side effects like nausea or vomiting tend to be milder and easier to manage
As an outcome, colonocytes shift to anaerobic metabolism characterised by reduced oxygen consumption thereby facilitating the growth of facultative anaerobes such as Enterobactericeae, which exploit the loss of epithelial hypoxia through aerobic respiration (Byndloss et al
Although GLP-1IIS and GIPIIS are both required to maintain blood glucose levels within normal range in healthy subjects, the reason why only GLP-1based treatments are effective in diabetes remains unknown
.png)
